Concomitant_pelvic_irradiation,_5-fluorouracil_and_mitomycin_C_in_the_treatment_of_advanced_cervical_carcinoma._This_was_a_Phase_II_study_of_24_late_(FIGO)_Stage_IIb_and_39_Stage_III_patients._External_beam_radiotherapy_was_given_daily,_five_days_a_week,_using_15_x_15_cm_parallel_opposed_pelvic_fields._The_first_20_patients_had_45.00_Gy_mid-plane_dose_in_20_fractions,_Days_1-28,_the_last_43_patients_had_50.40_Gy_in_28_fractions,_Days_1-43._This_was_followed_by_an_intracavitary_boost_of_17.00_Gy_to_Point_A_in_two_fractions_over_seven_days._The_first_seven_patients_had_concomitant_5-fluorouracil_(5FU)_1_g/m2/day_(maximum_1.5_g/day)_Days_2-5,_30-33_and_57-60,_with_mitomycin_C_10_mg/m2_(maximum_15_mg)_Days_2_and_57._Two_patients_had_WHO_Grade_4_cytopenia,_and_only_two_were_able_to_have_full_dose_intensity._The_5FU_dose_was_reduced_to_0.8_g/m2/day,_for_Days_2-5_and_30-33;_mitomycin_C_was_given_on_Day_2_only._Treatment_morbidity_with_the_reduced_chemotherapy_intensity_was_comparable_with_that_of_radiotherapy_alone._Median_follow-up_was_16_months_(range_6-44)._Median_survival_was_35_months._The_results_were_compared_with_historical_controls_treated_using_the_same_radiation_method_alone._Two-year_survival_for_late_Stage_IIb_patients_was_67%_with_the_combination_and_72%_with_radiotherapy_alone;_for_Stage_III,_67%_and_49%_respectively._Two-year_pelvic_control_for_late_Stage_IIb_was_87%_(combination)_and_84%_(radiotherapy_alone)_and_for_Stage_III,_61%_and_55%_respectively._In_contrast_to_reports_from_other_centres,_these_results_do_not_show_an_overall_significant_improvement_on_radiotherapy_alone._A_Phase_III_study_may_not_be_practicable.